FAM95C: A Promising Drug Target / Biomarker (G100289137)

Target Name: FAM95C

NCBI ID: G100289137

FAM95C

Other Name(s): Family with sequence similarity 95 member C | family with sequence similarity 95 member C

FAM95C: A Promising Drug Target / Biomarker

FAM95C is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its function is not well understood, but it is known to play a role in the regulation of cellular processes that are important for maintaining tissue health and function. While much research has been conducted on FAM95C, little is known about its specific role in the development or treatment of various diseases.

FAM95C as a Drug Target:
FAM95C has been identified as a potential drug target due to its involvement in a number of cellular processes that are important for disease development. One of the key functions of FAM95C is its role in the regulation of cellular signaling pathways, which are the channels through which hormones and other signaling molecules communicate with cells to regulate their behavior.

Research has shown that FAM95C is involved in a number of signaling pathways that are important for the development of various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. For example, studies have shown that FAM95C is involved in the regulation of the hedgehog signaling pathway, which is important for the development of neurodegenerative diseases such as Alzheimer's and Parkinson's.

In addition to its involvement in signaling pathways, FAM95C has also been shown to play a role in the regulation of cellular processes that are important for tissue repair and regeneration. This is important for diseases that involve tissue damage or regeneration, such as cancer.

FAM95C as a Biomarker:
FAM95C has also been identified as a potential biomarker for a number of diseases. This is because its expression is often altered in response to the presence of certain diseases, which can be used as a diagnostic or monitoring tool. For example, studies have shown that FAM95C is often expressed in the brains of individuals with Alzheimer's disease, which is a neurodegenerative disease that is characterized by the progressive loss of brain cells.

In addition to its potential as a biomarker, FAM95C has also been shown to be involved in the development of certain diseases. For example, studies have shown that FAM95C is involved in the regulation of the immune system, which is important for the development of autoimmune diseases such as rheumatoid arthritis and multiple sclerosis.

Conclusion:
FAM95C is a protein that is expressed in various tissues of the body and is involved in a number of cellular processes that are important for tissue health and function. While much research has been conducted on FAM95C, little is known about its specific role in the development or treatment of various diseases. As a potential drug target and biomarker, FAM95C has the potential to be a valuable tool in the development of new treatments for a number of diseases. Further research is needed to fully understand the role of FAM95C in disease development and to develop new treatments based on its properties.

Protein Name: Family With Sequence Similarity 95 Member C

The "FAM95C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAM95C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets